Pharmaceutical Contract Sales Outsourcing (CSO) Market: Global Industry Analysis and Forecast (2024-2030)

Pharmaceutical Contract Sales Outsourcing (CSO) Market is expected to grow at a CAGR of 7.2% throughout the forecast period, to reach US$ 19.14 Bn by 2030.

Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview:

Advancements and modifications in the pharmaceutical industry have made it necessary for many small and medium scale pharmaceutical companies to outsource their sales and marketing operations to contract service providers known as contract sales organizations (CSO). Outsourcing is an agreement in which one company hires another company to be responsible for a planned or existing activity.Pharmaceutical Contract Sales Outsourcing MarketTo Know About The Research Methodology :- Request Free Sample Report

Pharmaceutical Contract Sales Outsourcing (CSO) Market Dynamics:

Rapid growth of the pharmaceutical industry and companies operating in the sector are realizing the need to expand their geographical outreach. This is likely to escalate the growth of the global pharmaceutical contract sales market. Pharmaceutical industry has grown dynamically over the years due to increased global healthcare expenditures. Increasing demand for new drugs to cover the unmet clinical needs boosts the market growth. Despite these driving factors, declining profits due to expiration of patents, high cost associated with research & development and drug approval process are a few factors which may hamper the market growth. The report has profiled fifteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed.

Pharmaceutical Contract Sales Outsourcing (CSO) Market Segment Analysis:

The Global Pharmaceutical Contract Sales Outsourcing (CSO) Market is segmented on the basis of sales type and service type. Based on Sales Type, Dedicated sales model is the most commonly used model between drug manufacturer and pharmaceutical companies. The dedicated team model for outsourced projects connects the business with a team of specialists focused on the company’s projects’ goals.Hiring a dedicated team, the client gets full management control over the project and team.

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Regional Insights:

Regional Insights North America and Europe are expected to hold a dominant market share during forecast period. North America and Europe are estimated to account for more than 70-75% share of the overall revenues generated in the pharmaceutical contract sales industry globally. The regulatory and governing bodies monitor overall cost and quality of drugs, which increases the demand and acceptance of contract sales culture in these regions.Asia Pacific market is expected to grow at rapid pace due to Increase in disposable income, large patient population, and government intervention to improve healthcare and infrastructure. The report also helps in understanding Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Scope: Inquire before buying

Pharmaceutical Contract Sales Outsourcing (CSO) Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 11.76 Bn.
Forecast Period 2024 to 2030 CAGR: 7.2% Market Size in 2030: US $ 19.14 Bn.
Segments Covered: by Sales Type Dedicated sales model Syndicate sales model
by Service Type Personal promotion Non-personal promotion Other services

Pharmaceutical Contract Sales Outsourcing (CSO) Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Pharmaceutical Contract Sales Outsourcing (CSO) Market, Key players are:

1. Ashfield Commercial & Medical Services (UDG Healthcare PLC) 2.Publicis Touchpoint Solutions, Inc. 3. inVentiv Health, Inc. 4. QuintilesIMS 5. PDI, Inc. 6. Granard Pharmaceutical Sales & Marketing 7. Vanguard Pharma Inc. 8. GTS Solution 9. MABICO S.A. 10. Sales Partnerships, Inc. 11. Interpace BioPharma, LLC 12. Pharmexx UK 13. Marvecs 14. Sofip 15. Star Healthcare Frequently Asked questions 1. What is the market size of the Global Market in 2023? Ans. The market size Global Pharmaceutical Contract Sales Outsourcing (CSO) Market in 2023 was US$ 11.76 Billion. 2. What are the different segments of the Global Market ? Ans. The Global Market is divided into Sales Type and Service Type. 3. What is the study period of this market? Ans. The Global Market will be studied from 2023 to 2030 4. Which region is expected to hold the highest Global Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Market ? Ans. The Forecast Period of the market is 2024-2030 in the market.

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2023 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Pharmaceutical Contract Sales Outsourcing (CSO) Market 3.4. Geographical Snapshot of the Pharmaceutical Contract Sales Outsourcing (CSO) Market, By Manufacturer share 4. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Overview, 2023-2030 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market 5. Supply Side and Demand Side Indicators 6. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecast, 2023-2030 6.1. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size & Y-o-Y Growth Analysis. 7. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 7.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 7.1.1. Dedicated sales model 7.1.2. Syndicate sales model 7.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 7.2.1. Personal promotion 7.2.1.1. Sales force deployment 7.2.1.2. Vacancy management 7.2.1.3. Key account management 7.2.1.4. Physician education services 7.2.2. Non-personal promotion 7.2.2.1. Telesales 7.2.2.2. Medical call centers 7.2.2.3. Online marketing and sales 7.2.2.4. e-sampling 7.2.3. Other services 8. Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2023-2030 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 9.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 9.1.1. Dedicated sales model 9.1.2. Syndicate sales model 9.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 9.2.1. Personal promotion 9.2.1.1. Sales force deployment 9.2.1.2. Vacancy management 9.2.1.3. Key account management 9.2.1.4. Physician education services 9.2.2. Non-personal promotion 9.2.2.1. Telesales 9.2.2.2. Medical call centers 9.2.2.3. Online marketing and sales 9.2.2.4. e-sampling 9.2.3. Other services 10. North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 11.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 11.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 12. Canada Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 12.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 12.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 13. Mexico Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 13.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 13.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 14. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 14.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 14.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 15. Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 16.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 16.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 17. France Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 17.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 17.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 18. Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 18.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 18.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 19. Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 19.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 19.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 20. Spain Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 20.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 20.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 21. Sweden Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 21.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 21.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 22. CIS Countries Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 22.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 22.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 23. Rest of Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 23.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 23.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 24. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 24.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 24.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 25. Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 26.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 26.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 27. India Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 27.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 27.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 28. Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 28.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 28.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 29. South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 29.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 29.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 30. Australia Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 30.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 30.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 31. ASEAN Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 31.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 31.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 32. Rest of Asia Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 32.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 32.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 33. Middle East Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 33.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 33.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 34. Middle East Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 35.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 35.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 36. GCC Countries Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 36.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 36.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 37. Egypt Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 37.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 37.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 38. Nigeria Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 38.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 38.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 39. Rest of ME&A Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 39.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 39.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 40. South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 40.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 40.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 41. South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 42.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 42.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 43. Argentina Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 43.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 43.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 44. Rest of South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2023-2030 44.1. Market Size (Value) Estimates & Forecast By Sales Type, 2023-2030 44.2. Market Size (Value) Estimates & Forecast By Service Type, 2023-2030 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Ashfield Commercial & Medical Services (UDG Healthcare PLC) 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Publicis Touchpoint Solutions, Inc. 45.3.3. inVentiv Health, Inc. 45.3.4. QuintilesIMS 45.3.5. PDI, Inc. 45.3.6. Granard Pharmaceutical Sales & Marketing 45.3.7. Vanguard Pharma Inc. 45.3.8. GTS Solution 45.3.9. MABICO S.A. 45.3.10. Sales Partnerships, Inc. 45.3.11. Interpace BioPharma, LLC 45.3.12. Pharmexx UK 45.3.13. Marvecs 45.3.14. Sofip 45.3.15. Star Healthcare 46. Primary Key Insights
  • INQUIRE BEFORE BUYING
MMRLogo
America's Fastest Growing Market Research Firm